ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STX Shield Therapeutics Plc

1.35
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.35 1.15 1.40 - 0.00 07:34:33
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.26 10.47M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.35p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £10.47 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.26.

Shield Therapeutics Share Discussion Threads

Showing 22901 to 22918 of 23225 messages
Chat Pages: Latest  917  916  915  914  913  912  911  910  909  908  907  906  Older
DateSubjectAuthorDiscuss
21/2/2024
07:40
In fairness, this company has stunk for a long time now. This update is only consistent with what we have come to expect here. Need a total clear out, and possibly more. If the authorities had any credibility in the UK whatsoever, they would be all over this one. Dodgy as they come, is the impression they continue to create for themselves.
lovewinshatelosses
21/2/2024
07:37
Can't trust anything GM or the company spout anymore

Company is done for in my opinion in it's current state after today's news

Think AOP are going to get to step in here.. can't see any other way.. will VTRS buy after this? Highly unlikely.

tripletop1
21/2/2024
07:36
Want iron? Drink Guinness 100% natural
alancapone
21/2/2024
07:34
Naughty Naughty Cooking the numbersWill be needing more money Next Covenants breach coming
hamidahamida
21/2/2024
07:34
It's negligence, 3rd party data provider needed to count up to 28k, my child can do that
hatfullofsky
21/2/2024
07:32
Exactly has I predicted a few days ago disappointing and the CEO would try to put a positive spin .
Without doing a few hours number crunching the original 20 sales team without the partnership and massive extra costs and giving bear 50% away would have been approaching 55k YE so to say the 100 sales team have been successful is laughable

best1467
21/2/2024
07:27
100+ sales team and 22% growth, pathetic.

4p / 3p today ?

hatfullofsky
21/2/2024
07:24
Rebound trade at 1p
alancapone
21/2/2024
07:24
FFS !!!! This is going to hurt.

...... with the aim of turning cash flow positive in the second half of 2025(previous guidance late 2024)


Previously reported Group financials including revenues, net revenues per Accrufer® prescription, and compliance with financial covenants on the Group's debt instrument are not affected by this change. The Company is working closely with its third-party data provider to ensure future consistency of data reporting.

Madison has no shame, he doesn't mention the huge miss in his quote.

hatfullofsky
21/2/2024
07:18
Pick a positive selling price up 21%
little minx
21/2/2024
07:16
“With these revised prescription numbers, Shield is revisiting its previously communicated guidance and plans to provide additional updates at the time of the Company's final results, expected to be published in April 2024. Shield has also undertaken several important measures to manage its cash flow, including the reduction of operating expenses, and working capital enhancements, to provide the necessary resources with the aim of turning cash flow positive in the second half of 2025.”

How about firing the entire management team?

purchaseatthetop
21/2/2024
07:14
It doesn’t even make sense. End quarter figured (which are actual), were projected wrong ? You can’t blame a third party for our own accounts and cash flow not balancing.
Perfectly in time for their fund raise .
I really hope someone sues them, unbelievable.

2theduke
21/2/2024
07:10
Read the WHOLE rns. Overstated prescription numbers
babbler
21/2/2024
07:05
Figures look good to begin with but little detail on losses. It's OK increasing revenue albeit slower than previously thought but no indication of profit/loss so not worth much
bones698
20/2/2024
16:27
I see this is a usual trick played by mm, people are scared and selling your holding
qipincha
20/2/2024
15:54
Good volume today, sadly.Death by a thousand cuts
reviewwworld
17/2/2024
13:28
Nobbygnome - 30 Aug 2022 - 08:58:12 - 1542 of 1970
A few shorters will be panicking at this point

.....


😂

thanatos abyss
16/2/2024
07:15
Well With the scope Size of his Management team Greg needs to achieve something.
But many years of disappointment and achievement I’m not expecting anything positive On certainty he will put a positive spin on a negative

best1467
Chat Pages: Latest  917  916  915  914  913  912  911  910  909  908  907  906  Older

Your Recent History

Delayed Upgrade Clock